One Wealth Advisors LLC Has $884,000 Stock Holdings in Haleon PLC Sponsored ADR $HLN

One Wealth Advisors LLC reduced its stake in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 5.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 85,238 shares of the company’s stock after selling 5,196 shares during the quarter. One Wealth Advisors LLC’s holdings in Haleon were worth $884,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of HLN. Nuveen LLC bought a new stake in Haleon during the first quarter worth about $58,870,000. Millennium Management LLC increased its holdings in Haleon by 697.2% in the 1st quarter. Millennium Management LLC now owns 4,216,504 shares of the company’s stock valued at $43,388,000 after buying an additional 3,687,613 shares during the period. Wellington Management Group LLP raised its position in shares of Haleon by 22.0% in the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company’s stock valued at $192,428,000 after buying an additional 3,372,155 shares in the last quarter. Sculptor Capital LP lifted its holdings in shares of Haleon by 22.1% during the 1st quarter. Sculptor Capital LP now owns 10,849,868 shares of the company’s stock worth $111,645,000 after acquiring an additional 1,962,770 shares during the period. Finally, Jane Street Group LLC lifted its holdings in shares of Haleon by 933.1% during the 1st quarter. Jane Street Group LLC now owns 2,155,716 shares of the company’s stock worth $22,182,000 after acquiring an additional 1,947,050 shares during the period. Institutional investors own 6.67% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HLN. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Wall Street Zen lowered Haleon from a “buy” rating to a “hold” rating in a research note on Saturday, July 12th. Finally, The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $12.33.

Haleon Stock Performance

Shares of HLN stock opened at $8.83 on Tuesday. The firm has a market capitalization of $39.44 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 2.61 and a beta of 0.23. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. The business’s 50-day moving average price is $9.56 and its 200-day moving average price is $10.11. Haleon PLC Sponsored ADR has a 12 month low of $8.71 and a 12 month high of $11.42.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were given a $0.0555 dividend. This is an increase from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. This represents a yield of 190.0%. Haleon’s dividend payout ratio is currently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.